$1.03
+
$0.03 (3.00%)
End-of-day quote: 04/30/2024
NasdaqGS:KRON
Kronos Bio Annual Report
| Year | Year | 2022 | |||
|---|---|---|---|---|---|
| Rev. | Revenue |
|
$0.00M | ||
| GM % | Gross Margin % |
|
0.00% | ||
| OM | Operating Margin |
|
0.00% | ||
| EPS | Earnings Per Share |
|
$0.00 | $-2.37 | $-2.37 |
| Div. | Dividends |
|
$0.00 | ||
| PR % | Payout Ratio % |
|
0 | ||
| Sha. | Shares |
|
56.97m | ||
| OCF | Operating Cash Flow |
|
$-90.93M | ||
| FCF | Free Cash Flow |
|
$-91.50M | ||
| FCFS | Free Cash Flow Per Share |
|
$-1.63 |
